Ajo LP bought a new stake in Luminex Corp. (NASDAQ:LMNX) during the second quarter, Holdings Channel reports. The institutional investor bought 110,778 shares of the company’s stock, valued at approximately $2,241,000. Ajo LP owned approximately 0.25% of Luminex Corp. at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of LMNX. BlackRock Fund Advisors increased its position in shares of Luminex Corp. by 1.6% in the first quarter. BlackRock Fund Advisors now owns 3,017,364 shares of the company’s stock valued at $58,537,000 after buying an additional 46,200 shares in the last quarter. Prudential Financial Inc. increased its position in shares of Luminex Corp. by 5.3% in the first quarter. Prudential Financial Inc. now owns 93,840 shares of the company’s stock valued at $1,820,000 after buying an additional 4,700 shares in the last quarter. Aperio Group LLC increased its position in shares of Luminex Corp. by 36.6% in the first quarter. Aperio Group LLC now owns 13,048 shares of the company’s stock valued at $253,000 after buying an additional 3,499 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Luminex Corp. by 19.1% in the first quarter. Renaissance Technologies LLC now owns 1,007,840 shares of the company’s stock valued at $19,552,000 after buying an additional 161,800 shares in the last quarter. Finally, BlackRock Group LTD increased its position in shares of Luminex Corp. by 4.6% in the first quarter. BlackRock Group LTD now owns 64,271 shares of the company’s stock valued at $1,247,000 after buying an additional 2,828 shares in the last quarter. Institutional investors and hedge funds own 80.50% of the company’s stock.

Shares of Luminex Corp. (NASDAQ:LMNX) traded up 0.18% during trading on Monday, hitting $21.90. The company had a trading volume of 42,370 shares. Luminex Corp. has a 52 week low of $16.16 and a 52 week high of $23.75. The firm’s 50 day moving average is $21.54 and its 200-day moving average is $20.50. The stock has a market capitalization of $953.70 million, a P/E ratio of 22.86 and a beta of 0.45.

Luminex Corp. (NASDAQ:LMNX) last posted its quarterly earnings data on Thursday, July 28th. The company reported $0.33 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.18. The company earned $64.20 million during the quarter, compared to analysts’ expectations of $61.20 million. Luminex Corp. had a return on equity of 13.65% and a net margin of 16.60%. Luminex Corp.’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.27 earnings per share. Equities research analysts anticipate that Luminex Corp. will post $0.63 EPS for the current fiscal year.

Several analysts have weighed in on the company. Zacks Investment Research cut Luminex Corp. from a “buy” rating to a “hold” rating in a report on Monday, July 4th. JPMorgan Chase & Co. raised Luminex Corp. from an “underweight” rating to a “neutral” rating and raised their price target for the company from $18.00 to $22.00 in a report on Thursday, August 18th. Finally, Jefferies Group raised their price target on Luminex Corp. from $21.00 to $23.00 and gave the company a “hold” rating in a report on Thursday, July 28th. Six investment analysts have rated the stock with a hold rating, The stock has a consensus rating of “Hold” and a consensus price target of $22.20.

About Luminex Corp.

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company has a range of instruments using its xMAP technology, including its LUMINEX 100/200 systems offer 100-plex testing; the Company’s FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry.

5 Day Chart for NASDAQ:LMNX

Want to see what other hedge funds are holding LMNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Luminex Corp. (NASDAQ:LMNX).

Receive News & Ratings for Luminex Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminex Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.